EV Biologics, Inc. (YECO)

EV Biologics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	0.13	0.34	0.6	0.1	0
Cash & Cash Equivalents	0.13	0.34	0.6	0.1	0
Cash Growth	-62.16%	-44.15%	485.37%	-	-
Receivables	0.27	0.25	0.12	0	4.81
Inventory	0	0	0	0	0.4
Other Current Assets	0	0	0	0	1.29
Total Current Assets	0.39	0.59	0.72	0.1	6.5
Property, Plant & Equipment	0.04	0	6.94	6.94	6.96
Long-Term Investments	0	0	2.41	0	15.3
Other Long-Term Assets	-0	10.84	21.27	2.01	0.18
Total Long-Term Assets	0.04	10.84	30.62	8.95	24.45
Total Assets	0.43	11.42	31.34	9.05	30.95
Accounts Payable	0.1	0.21	0	0	2.23
Deferred Revenue	0	0	0	0	1.29
Current Debt	1.49	22.68	21.68	0	10.04
Other Current Liabilities	0.52	2.37	2.44	1.44	15.93
Total Current Liabilities	2.12	25.26	24.12	1.44	29.49
Total Liabilities	2.12	25.26	24.12	1.44	29.49
Total Debt	1.49	22.68	21.68	0	10.04
Debt Growth	-93.41%	4.59%	-	-	55.13%
Common Stock	0.01	0.01	0.01	0.01	0.04
Retained Earnings	-49.32	-58.47	-37.42	-37.03	-41.72
Comprehensive Income	3.92	3.92	3.92	3.92	2.42
Shareholders' Equity	-1.68	-13.83	7.22	7.61	1.46
Total Liabilities and Equity	0.43	11.42	31.34	9.05	30.95
Net Cash / Debt	-1.37	-22.34	-21.08	0.1	-10.04
Net Cash Per Share	-0.13	-3.09	-2.92	0.01	-1.56
Working Capital	-1.72	-24.67	-23.41	-1.34	-22.99
Book Value Per Share	-0.16	-1.91	1.00	1.05	0.23

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.